Redirecting the Immune Microenvironment in Acute Myeloid Leukemia

SIMPLE SUMMARY: Despite remarkable progress in the outcome of childhood acute myeloid leukemia (AML), risk of relapse and refractory diseases remains high. Treatment of the chemo-refractory disease is restricted by dose-limiting therapy-related toxicities which necessitate alternative tolerable effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sendker, Stephanie, Reinhardt, Dirk, Niktoreh, Naghmeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003817/
https://www.ncbi.nlm.nih.gov/pubmed/33804676
http://dx.doi.org/10.3390/cancers13061423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003817/
https://www.ncbi.nlm.nih.gov/pubmed/33804676
http://dx.doi.org/10.3390/cancers13061423

Ejemplares similares